J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 51(10); 2008 > Article
Lee: Drug Treatment of Herpes Simplex Infection

Abstract

Herpes simplex virus (HSV) is one of Herpesviridae family viruses which belong to DNA viruses. HSV-associated diseases are among the most widespread infections, affecting nearly 60% to 95% of human adults. Labial herpes typically results from infection with HSV type 1 (HSV-1), whereas most genital herpes is caused by HSV type 2 (HSV-2). They are incurable and persist during the lifetime of the host, often in latent form. Antiviral agents do not cure HSV infections, but rather modify the clinical course of the disease. Topical, oral, or intravenous antiviral agents may be used in the management of HSV infections. Acyclovir, valacyclovir hydrochloride, and famciclovir are the 3 antiviral drugs commonly used to treat symptomatic HSV infections. However, it is very difficult to choose an appropriate drug and dosing regimen.

References

1. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol 2007;57:737-763. quiz 64-66.

2. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med 2008;168:1137-1144.

3. KDA. Textbook Editing Board. Dermatology 2008;5th ed. Seoul: Ryo Moon Gak. 386-389.

4. Marques AR, Strauss SE. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller A, Leffell DJ, editor. Herpes simplex. Fitzpatrick's dermatology in general medicine 2007;7th ed. Columbus: McGraw-Hill. 1873-1885.

5. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55(RR-11):1-94.

Figure 1
Herpes labialis.
jkma-51-942-g001-l.jpg
Figure 2
Herpetic whitlow.
jkma-51-942-g002-l.jpg
Figure 3
Eczema herpeticum.
jkma-51-942-g003-l.jpg
Table 1
Chronic suppressive therapy for herpes labialis
jkma-51-942-i001-l.jpg
Table 2
Intermittent episodic treatment for genital herpes
jkma-51-942-i002-l.jpg
Table 3
Chronic suppressive therapy for genital herpes
jkma-51-942-i003-l.jpg


ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next